BNGO - bionanogenomics.com Full Takeover Company Value

Graphic logo of bionanogenomics.com (BNGO)

The market trend for Bionano Genomics, Inc. (BNGO) shares on the GURU.Markets platform, which currently stands at 10.41, highlights the risks of the company's narrow specialization in a single genome analysis technology. Business development is tied to government subsidy cycles and scientific budgets, which defines its investment nature. Ultimate stability relies on a fabless production model and the reliability of third-party equipment assemblers in the US.

bionanogenomics.com (BNGO) Enterprise Value: for the period 11/23/2025 - 10/30/2026

Bionano Genomics (BNGO) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price Bionano Genomics Inc.|BNGO - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Bionano Genomics|BNGO - Total Company Value
- company book value details:
Net Asset Value per Share Bionano Genomics|BNGO - Book Capitalization|Capitalization to Book Value Ratio bionanogenomics.com|BNGO - Aggregate Company Assets
- debt level and financial liquidity data:
Debt to Equity Ratio Bionano Genomics, Inc.|BNGO - Long-Term Debt to Capital|Short-Term Debt to Capital Bionano Genomics Inc.|BNGO - Company Aggregate Debts|Debt to Book Capitalization Ratio Bionano Genomics|BNGO - Company Long-Term Debts|Short-Term Debt Volume Bionano Genomics|Immediate Liquidity bionanogenomics.com
- earnings and market multiples details:
BNGO - Company Net Income
Summary company analytics:Bionano Genomics, Inc. (BNGO)
Flagship merchandise of Bionano Genomics

The EV trend reflects the market value of Bionano Genomics, Inc. (BNGO) accounting for its debt load and liquidity, which is critical for assessing the scaling of optical genome mapping systems. This metric is calculated as the sum of market capitalization and debt minus cash, determining the actual acquisition price of the business and its real investment attractiveness for a strategic buyer.

Who Bionano Genomics, Inc. competes with

TEM: Business Value|Qiagen Group - Enterprise Value|Full Takeover Company Value Isis Pharmaceuticals (IONS)|Repligen Corporation (RGEN) - Total Company Value|Total Enterprise Value aviditybiosciences.com (RNA)|CRSP (CRISPR Therapeutics) - Enterprise Value|Business Value WGS (GeneDx Holdings)|Total Company Value Ultragenyx Pharma (RARE)|Beam Tx - Business Value|Enterprise Value SRPT (Sarepta Therapeutics, Inc.)|Enterprise Value twistbioscience.com TWST|10x Genomics - Enterprise Value|NTLA: Total Company Value|STOK: Enterprise Value|BLFS - Company Buyout Price|Total Company Value Wave Life Sciences|Total Enterprise Value mazetx.com MAZE|Total Company Value Sionna Therapeutics (SION)|Prime Medicine Inc - Business Value|Enterprise Value TSHA (Taysha)|Enterprise Value uniQure Pharma QURE|MGTX - Total Company Value|RGNX (regenxbio.com) - Business Value|Solid Biosciences (SLDB) - Total Company Value|Total Enterprise Value Ocugen Inc (OCGN)|Real Price to Acquire Entire Company PACB|BNTC: Value Adjusted for Debt and Cash|Enterprise Value DSGN|rocketpharma.com (RCKT) - Full Takeover Company Value|Enterprise Value FDMT (4D Molecular Therapeutics, Inc.)|Lexeo Therapeutics Inc. (LXEO) - Total Enterprise Value|KRRO - Total Company Value|EDIT (Editas Corp) - Business Value|Silence Therapeutics (SLN) - Total Company Value|Total Enterprise Value ProQR Therapeutics (PRQR)|Total Company Value Codexis Inc|Real Price to Acquire Entire Company Sangamo Therapeutics Inc. (SGMO)|Enterprise Value NAUT|Company Buyout Price Metagenomi Therapeutics|Enterprise Value DTIL (Precision BioSciences, Inc.)|GBIO - Real Price to Acquire Entire Company|BOLD - Total Company Value|Company Buyout Price Exicure, Inc. XCUR|IMNN (imunon.com) - Real Price to Acquire Entire Company|Phio Pharmaceuticals Corp. - Value Adjusted for Debt and Cash|MBIO (Mustang Bio Inc) - Enterprise Value|TransCode (RNAZ) - Company Buyout Price|Total Company Value Applied DNA Sciences, Inc. (APDN)|bluebird bio Inc. - Business Value|Enterprise Value IPA (ImmunoPrecise Antibodies Ltd.)|OMGA - Real Price to Acquire Entire Company|OMIC: Real Price to Acquire Entire Company|Company Buyout Price regulusrx.com RGLS|SYRS: Enterprise Value|TBIO (Telesis Bio Inc.) - Total Company Value|Total Company Value TRACON|Business Value UBX (Unity Biotechnology, Inc)